Quantitative trait locus analysis reveals two intragenic sites that influence O6-alkylguanine-DNA alkyltransferase activity in peripheral blood mononuclear cells.
AuthorsMargison, Geoffrey P
Pearson, Steven J
Thorncroft, Mary R
Watson, Amanda J
Harrison, Kathryn L
Lewis, Sarah J
Barber, Philip V
Povey, Andrew C
Santibanez-Koref, Mauro F
AffiliationCancer Research-UK Carcinogenesis Group, Paterson Institute for Cancer Research, Christie Hospital NHS Trust, Manchester, UK. email@example.com
MetadataShow full item record
AbstractThe repair of specific types of DNA alkylation damage by O6-alkylguanine-DNA alkyltransferase (MGMT) is a major mechanism of resistance to the carcinogenic and chemotherapeutic effects of certain alkylating agents. MGMT expression levels vary widely between individuals but the underlying causes of this variability are not known. To address this, we used an expressed single nucleotide polymorphism (SNP) and demonstrated that the MGMT alleles are frequently expressed at different levels in peripheral blood mononuclear cells (PBMC). This suggests that there is a genetic component of inter-allelic variation of MGMT levels that maps close to or within the MGMT locus. We then used quantitative trait locus (QTL) analysis using intragenic SNPs and found that there are at least two sites influencing inter-individual variation in PBMC MGMT activity. One is characterized by an SNP at the 3' end of the first intron and the second by two SNPs in the last exon. The latter are in perfect disequilibrium and both result in amino acid substitutions-one of them, Ile143Val, affecting an amino acid close to the Cys145 residue at the active site of MGMT. Using in vitro assays, we further showed that while the Val143 variant did not affect the activity of the protein on methylated DNA substrate, it was more resistant to inactivation by the MGMT pseudosubstrate, O6-(4-bromothenyl)guanine. These findings suggest that further investigations of the potential epidemiological and clinical significance of inherited differences in MGMT expression and activity are warranted.
CitationQuantitative trait locus analysis reveals two intragenic sites that influence O6-alkylguanine-DNA alkyltransferase activity in peripheral blood mononuclear cells. 2005, 26 (8):1473-80 Carcinogenesis
- The alleles of the DNA repair gene O6-alkylguanine-DNA alkyltransferase are expressed at different levels in normal human lung tissue.
- Authors: Heighway J, Margison GP, Santibáñez-Koref MF
- Issue date: 2003 Oct
- Genetic variants in MGMT and risk of lung cancer in Southeastern Chinese: a haplotype-based analysis.
- Authors: Hu Z, Wang H, Shao M, Jin G, Sun W, Wang Y, Liu H, Wang Y, Ma H, Qian J, Jin L, Wei Q, Lu D, Huang W, Shen H
- Issue date: 2007 May
- Specific recognition of O6-methylguanine in DNA by active site mutants of human O6-methylguanine-DNA methyltransferase.
- Authors: Hazra TK, Roy R, Biswas T, Grabowski DT, Pegg AE, Mitra S
- Issue date: 1997 May 13
- Cisplatin represses transcriptional activity from the minimal promoter of the O6-methylguanine methyltransferase gene and increases sensitivity of human gallbladder cancer cells to 1-(4-amino-2-methyl-5-pyrimidinyl) methyl-3-2-chloroethyl)-3-nitrosourea.
- Authors: Sato K, Kitajima Y, Nakagawachi T, Soejima H, Miyoshi A, Koga Y, Miyazaki K
- Issue date: 2005 May
- Novel O6-methylguanine-DNA methyltransferase SNPs: a frequency comparison of patients with familial melanoma and healthy individuals in Sweden.
- Authors: Egyházi S, Ma S, Smoczynski K, Hansson J, Platz A, Ringborg U
- Issue date: 2002 Nov